Business
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nWOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) (\"Endonovo\" or the \"Company\"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic devices, announced today its initial plans and strategy for a national rollout of its SofPulse® targeted pulsed electromagnetic field (tPEMF) therapy device to hospitals throughout the United States.\n The Company has recently signed agreements with six master distributors and has hired approximately 40 sales associates. Endonovo’s plan is to have 300 sales representatives and be in the evaluation stage with 600 hospitals within the next 18 months. To support the national rollout, Endonovo has appointed Ken Snider as national sales manager and DevicePharm as marketing firm of record. Ken Snider started his career in pharmaceutical sales in 1989 with Pfizer Inc. as a primary care representative selling products for the treatment of high blood pressure, diabetes and arthritis. Ken was promoted to work at Pfizer Headquarters in New York City as curriculum development manager, writing learning systems and sales training systems for 15 different products. Throughout Ken’s tenure at Pfizer, he was responsible for developing the sales training materials for national launch meetings, regional sales meetings and district sales meetings. Ken was also the product presenter for some of the most successful products in Pfizer and pharmaceutical industry history. DevicePharm is a marketing strategy and integrated marketing solutions firm for organizations serving medical professionals and healthcare consumers. Since 2002, DevicePharm has served dozens of medical device, biotech and life science companies as well as select healthcare service firms in the United States and around the world. The team has launched over 500 healthcare brands and has been recognized with dozens of awards for marketing strategy, marketing campaign effectiveness, medical advertising, direct-to-consumer advertising, digital and interactive media and creative excellence. Alan Collier, Endonovo’s chief executive officer, stated, “After careful consideration and discussions, and in accordance with our internal budgets, we have reached the point at which we can confidently announce our national rollout plan and s...